TY - JOUR KW - California KW - Combined Modality Therapy KW - Depressive Disorder/economics/ethnology/etiology/therapy KW - Female KW - Follow-Up Studies KW - Hispanic Americans/psychology KW - Humans KW - Male KW - Middle Aged KW - Neoplasms/economics/psychology KW - Patient Care Team KW - Patient Satisfaction KW - Poverty/economics/psychology KW - Psychiatric Status Rating Scales KW - Quality of Life KW - Recurrence/prevention & control AU - K. Ell AU - B. Xie AU - S. Kapetanovic AU - D. I. Quinn AU - P. J. Lee AU - A. Wells AU - C. P. Chou A1 - AB - OBJECTIVE: This study assessed longer-term outcomes of low-income patients with cancer (predominantly female and Hispanic) after treatment in a collaborative model of depression care or in enhanced usual care. METHODS: The randomized controlled trial, conducted in safety-net oncology clinics, recruited 472 patients with major depression symptoms. Patients randomly assigned to a 12-month intervention (a depression care manager and psychiatrist provided problem-solving therapy, antidepressants, and symptom monitoring and relapse prevention) or enhanced usual care (control group) were interviewed at 18 and 24 months after enrollment. RESULTS: At 24 months, 46% of patients in the intervention group and 32% in the control group had a >/=50% decrease in depression score over baseline (odds ratio=2.09, 95% confidence interval=1.13-3.86; p=.02); intervention patients had significantly better social (p=.03) and functional (p=.01) well-being. Treatment receipt among intervention patients declined (72%, 21%, and 18% at 12, 18, and 24 months, respectively); few control group patients reported treatment receipt (10%, 6%, and 13%, respectively). Significant differences in receipt of counseling or antidepressants disappeared at 24 months. Depression recurrence was similar between groups (intervention, 36%; control, 39%). Among patients with depression recurrence, intervention patients were more likely to receive treatment after 12 months (34% versus 10%; p=.03). At 24 months, attrition (262 patients, 56%) did not vary by group; 22% were deceased, 20% declined further participation, and 14% could not be located. CONCLUSIONS: Collaborative care reduced depression symptoms and enhanced quality of life; however, results call for ongoing depression symptom monitoring and treatment for low-income cancer survivors. BT - Psychiatric services (Washington, D.C.) C5 - Healthcare Disparities CP - 2 CY - United States DO - 10.1176/appi.ps.62.2.162 IS - 2 JF - Psychiatric services (Washington, D.C.) N2 - OBJECTIVE: This study assessed longer-term outcomes of low-income patients with cancer (predominantly female and Hispanic) after treatment in a collaborative model of depression care or in enhanced usual care. METHODS: The randomized controlled trial, conducted in safety-net oncology clinics, recruited 472 patients with major depression symptoms. Patients randomly assigned to a 12-month intervention (a depression care manager and psychiatrist provided problem-solving therapy, antidepressants, and symptom monitoring and relapse prevention) or enhanced usual care (control group) were interviewed at 18 and 24 months after enrollment. RESULTS: At 24 months, 46% of patients in the intervention group and 32% in the control group had a >/=50% decrease in depression score over baseline (odds ratio=2.09, 95% confidence interval=1.13-3.86; p=.02); intervention patients had significantly better social (p=.03) and functional (p=.01) well-being. Treatment receipt among intervention patients declined (72%, 21%, and 18% at 12, 18, and 24 months, respectively); few control group patients reported treatment receipt (10%, 6%, and 13%, respectively). Significant differences in receipt of counseling or antidepressants disappeared at 24 months. Depression recurrence was similar between groups (intervention, 36%; control, 39%). Among patients with depression recurrence, intervention patients were more likely to receive treatment after 12 months (34% versus 10%; p=.03). At 24 months, attrition (262 patients, 56%) did not vary by group; 22% were deceased, 20% declined further participation, and 14% could not be located. CONCLUSIONS: Collaborative care reduced depression symptoms and enhanced quality of life; however, results call for ongoing depression symptom monitoring and treatment for low-income cancer survivors. PP - United States PY - 2011 SN - 1557-9700; 1075-2730 SP - 162 EP - 170 EP - T1 - One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer T2 - Psychiatric services (Washington, D.C.) TI - One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer U1 - Healthcare Disparities U2 - 21285094 U3 - 10.1176/appi.ps.62.2.162 VL - 62 VO - 1557-9700; 1075-2730 Y1 - 2011 ER -